DI MARIO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.504
AS - Asia 642
EU - Europa 607
SA - Sud America 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.772
Nazione #
US - Stati Uniti d'America 4.495
CN - Cina 312
SG - Singapore 267
SE - Svezia 135
FI - Finlandia 120
DE - Germania 95
GB - Regno Unito 53
RU - Federazione Russa 53
FR - Francia 48
UA - Ucraina 47
VN - Vietnam 31
HK - Hong Kong 20
IT - Italia 20
BR - Brasile 12
IE - Irlanda 8
IN - India 8
NL - Olanda 6
RO - Romania 6
CA - Canada 5
RS - Serbia 3
AU - Australia 2
CZ - Repubblica Ceca 2
PA - Panama 2
PL - Polonia 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BT - Bhutan 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LU - Lussemburgo 1
TR - Turchia 1
VE - Venezuela 1
Totale 5.772
Città #
Fairfield 586
Chandler 429
Woodbridge 414
Houston 413
Ashburn 311
Wilmington 250
Ann Arbor 244
Santa Clara 226
Jacksonville 219
Cambridge 199
Singapore 192
Seattle 191
Princeton 137
Boardman 132
San Diego 71
Beijing 68
Medford 63
Nanjing 56
Helsinki 33
Dong Ket 30
Guangzhou 30
Roxbury 28
Des Moines 22
Changsha 20
Hong Kong 20
Nanchang 20
Norwalk 20
Hebei 15
Shenyang 14
London 12
Washington 12
Tianjin 11
Falls Church 10
Jiaxing 9
New York 9
Dallas 7
Dublin 7
Edinburgh 6
Frankfurt am Main 6
San Jose 6
Auburn Hills 5
Jinan 5
Los Angeles 5
Nuremberg 5
Redwood City 5
Borås 4
Chicago 4
Kharkiv 4
Milan 4
Ningbo 4
Ogden 4
Shanghai 4
Tappahannock 4
Belgrade 3
Horia 3
Indiana 3
Timisoara 3
Amsterdam 2
Asunción 2
Brisbane 2
Florence 2
Las Vegas 2
Mestre 2
Ottawa 2
Padova 2
Panama City 2
Pune 2
Rockville 2
Warsaw 2
Adana 1
Araxá 1
Augusta 1
Belize City 1
Bishkek 1
Brasília 1
Brno 1
Brussels 1
Champlain 1
Chengdu 1
Chongqing 1
Copenhagen 1
Dongguan 1
Dongying 1
Easton 1
Foshan 1
Frankfurt Am Main 1
Fulham 1
Fuzhou 1
General Salgado 1
Haikou 1
Hangzhou 1
Hanoi 1
Hazleton 1
Hendon 1
Hounslow 1
Keflavik 1
Kilburn 1
Kunming 1
Lehrte 1
Limón 1
Totale 4.672
Nome #
Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade. 154
Natural course of functional dyspepsia after Helicobacter pylori eradication: A seven-year survey 151
Actual role of pepsinogen group I in the study of upper gastrointestinal diseases 138
H-pylori eradication and gastric precancerous lesions 119
Serum pepsinogen C: a useful marker of Helicobacter pylori eradication? 112
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study. 111
Laboratory medicine in ulcer disease. 110
Chronic nicotine intake causes vascular dysregulation in the rat gastric mucosa. 110
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology 104
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study. 102
Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase 101
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 101
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey 98
Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease. 97
Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients 95
Early epigastric pain after PPI administration: Exacerbation of Helicobacter pylori corpus gastritis? 93
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 90
Measurement of tryptase in endoscopic gastroduodenal biopsies: distribution and relationship with ulcer disease. 88
Recovery of gastric function after helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study 86
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. 82
Polymorphonuclear oxidative burst after Helicobacter pylori water extract stimulation is not influenced by the cytotoxic genotype but indicates infection and gastritis grade. 82
The long term outcome of gastric non-invasive neoplasia. 80
Carcinogenetic potential of the WSR cagA region. 77
Identification of the phenotype of the gastric mucosa in patient's with Barrett's esophagus with and without H-pylori infection 76
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. 74
Retreatment after failure of Helicobacter pylori eradication: Quadruple vs ranitidine bismuth citrate 2 weeks therapy. 73
Gastric epithelial dysplasia and sulphomucin-type intestinal metaplasia. 73
Effect of storage time on peptic activity in gastric biopsies. 73
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. 72
Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 72
EARLY AND ADVANCED GASTRIC-CANCER IN THE FOLLOW-UP OF MODERATE AND SEVERE GASTRIC DYSPLASIA PATIENTS - A PROSPECTIVE-STUDY 72
Radioimmunoassay for pepsinogen C 71
Serum Pepsinogen Assays and Gastric Acid Secretion 71
Helicobacter pylori activates gastric mucosal mast cells. 70
[Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis]. 70
Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer. 69
Relationship between psychosocial factors and serum level of pepsinogen group I and gastrinemia in the normal subject. 69
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 69
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. 69
Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions 67
The outcome of low and high grade of chronic atrofic gastritis (CAG) after Helicobacter pylori infection eradication: A 3 years follow-up 67
[Morpho-functional characteristics of reflux gastritis in patients after cholecystectomy and without cholecystectomy]. 65
PPIS plus H-2-antagonists for non-responders GERD patients: A rescue therapy? (A three months pilot study). 65
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 64
[Alcohol-dependent mast cell activation in ulcer]. 60
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 59
[Ca 19-9 in the diagnosis of pancreatic carcinoma]. 59
Utilità  clinica della curva gastrinemica dopo pasto proteico nella malattia ulcerosa duodenale. 58
Identification of new IL12A and IL12B genes polymorphisms as host genetic factors interplaying with H. pylori 57
Diagnosis of Helicobacter pylori infection: comparison of techniques. 56
Rabeprazole in a one-week eradication therapy of Helicobacter pylori: Comparison of different dosages 55
Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies. 55
[Basal and postprandial blood gastrin in peptic ulcer. The physiopathological aspects in relation to different sites of the lesion]. 54
Limits of CEA and ferritin in the diagnosis of pancreatic cancer. 54
[Gastrin tissue levels in patients with peptic ulcer: a different methodological approach]. 53
Do ranitidine and nizatidine influence pepsin secretion? 53
Il Ca 19-9 nella diagnosi di carcinoma pancreatico 53
The dark side of the gastric biopsy 52
The "very bed" H pylori: Experience on 69 consecutive patients after the failure of the second eradication treatment. 52
Benign and malignant gastric ulcers: is their localization relevant in their differential diagnosis? 51
[Cigarette smoking and group I pepsinogen levels. Study in a normal population]. 51
Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection. 49
[Raised levels of IgE and allergic diseases in patients subjected to esophagogastroduodenoscopy]. 49
Synergistic effect of H. pylori infection and interleukin 12 polymorphisms for the development of gastric cancer 48
[Does Helicobacter pylori have a direct proteolytic effect in ulcerative disease?]. 48
Comparison of different dosages of PPI in one-week Helicobacter pylori eradication therapy 47
[The effects of nizatidine and misoprostol on peptic activity and gastric mucus]. 46
[Gastric ulcer, duodenal ulcer and major and minor blood groups. Epidemiological aspects, functional correlations, clinical implications]. 45
GASTRIC INVOLVEMENT IN PRIMARY SJOGRENS-SYNDROME 44
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL-1RN host genes in favoring preneoplastic and neoplastic gastric lesions 43
Effects of H2 blockers and omeprazole on peptic secretion: a prospective, randomized study in duodenal ulcer subjects. 43
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 43
The role of the laboratory in the diagnosis and monitoring of Helicobacter pylori infection. 42
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL1-RN host genes in favoring preneoplastic and neoplastic gastric lesions 41
[Pepsinogen]. 40
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia. 39
High IgE serum levels and "peptic" ulcers: clinical and functional approach. 36
Atlante a colori delle malattie dell'apparato digerente. Malattie dello stomaco. 35
Tumor necrosis factor alpha (TNFa), Interferon Gamma (IFNg), IL10 host gene polymorphisms and H. pylori infection 35
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL-1RN host genes in favoring preneoplastic and neoplastic gastric lesions 34
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients. 33
Serological tests to monitor treatment of Helicobacter pylori 32
Smoking habit on gastric bicarbonate secretion in patients with duodenal ulcer. 25
The natural history of duodenal ulcer disease. 24
Does alcohol activate mast cells in peptic ulcer? 24
Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. 20
Pathophysiology of the gastric microcirculation. 17
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 12
Totale 5.778
Categoria #
all - tutte 23.176
article - articoli 21.124
book - libri 154
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 0 0 0 0 0 0 0 103 94 109 58 37
2020/2021564 29 36 16 101 20 54 7 35 86 38 76 66
2021/2022955 12 154 76 85 68 48 36 109 30 13 96 228
2022/2023879 175 84 3 103 173 111 1 74 93 4 48 10
2023/2024383 19 59 47 26 42 66 20 11 9 7 37 40
2024/2025792 2 146 74 85 318 53 78 36 0 0 0 0
Totale 5.778